Final answer:
Suppliers in the U.S. health care system include pharmaceutical and biotechnology companies, government-sponsored plans, and public health agencies. Public healthcare is government-funded while private healthcare is privately funded, reflecting different types of coverage. The FDA ensures medication safety but can inadvertently cause delays in patient access to new treatments.
Step-by-step explanation:
The types of organizations that act as suppliers within the U.S. health care system include pharmaceutical companies, which develop and provide medications; biotechnology companies, which offer products based on genetic and biomolecular technologies; government-sponsored plans like Medicare, which primarily offers insurance to people over sixty-five years old; and public health agencies, which play roles in vaccination, disease prevention, and health education. Private healthcare systems can consist of entities such as a private hospital or a nonprofit health organization. On the other hand, public healthcare is funded by governmental bodies like the Department of Health and Social Services. The U.S. healthcare system has seen a shift towards mass production and efficiency, with local healthcare providers often merging into larger systems to handle increasing demand. The Food and Drug Administration (FDA) plays a critical role in ensuring the safety and efficacy of medicines sold in the U.S., which requires companies to conduct extensive testing before market release. While this protects from unsafe drugs, there are also more anonymous losers in this system, such as patients who might suffer because they cannot access potentially beneficial treatments while they are under long testing periods.